SCHEMBL20174237

SCHEMBL20174237

c1ccc(-c2ccc(-c3nc(-c4ccccc4)nc(-c4ccccc4-c4cccc5c4-c4oc6ccccc6c4C54c5ccccc5-c5ccccc54)n3)cc2)cc1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 1/20 0.32
PLA2G4A P47712 1/20 0.32
MAPT P10636 5/20 0.32
TSHR P16473 4/20 0.32
KDM4E B2RXH2 4/20 0.32
ALDH1A1 P00352 4/20 0.32
L3MBTL1 Q9Y468 3/20 0.32
HPGD P15428 3/20 0.32
TP53 P04637 2/20 0.32
MAPK1 P28482 2/20 0.32
HSD17B10 Q99714 2/20 0.32
NFKB1 P19838 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32
ATM Q13315 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
KMT2A Q03164 3/20 0.31
LMNA P02545 2/20 0.31
POLB P06746 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20174231 0.92 MAPT (0.34) PLA2G2APLA2G4AMAPTTSHRKDM4E
SCHEMBL20174274 0.90 PLA2G2A (0.33) PLA2G2APLA2G4AMAPTTSHRKDM4E
SCHEMBL20174275 0.87 KMT2A (0.32) PLA2G2APLA2G4AMAPTKDM4EALDH1A1
SCHEMBL20174250 0.87 ALDH1A1 (0.35) PLA2G2APLA2G4AMAPTTSHRKDM4E
SCHEMBL20174263 0.87 KMT2A (0.36) PLA2G2APLA2G4AMAPTKDM4EALDH1A1
SCHEMBL20174212 0.87 KMT2A (0.33) PLA2G2APLA2G4AMAPTTSHRKDM4E
SCHEMBL20174298 0.86 L3MBTL1 (0.31) PLA2G2APLA2G4AL3MBTL1
SCHEMBL20174283 0.86 CA1 (0.35) PLA2G2APLA2G4AMAPTKDM4EALDH1A1
SCHEMBL20174232 0.85 PDK2 (0.33) PLA2G2APLA2G4AMAPTKDM4EALDH1A1
SCHEMBL20174203 0.83 MAPT (0.33) PLA2G2APLA2G4AMAPTTSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738034-B2 Spiro compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2020-08-11 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738034-B2 Spiro compound and organic light-emitting device comprising same CRY1, NR2E3, ERG PLA2G2A 4788/4885PLA2G4A 4802/4885MAPT 811/4885
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, NR2E3, ERG PLA2G2A 4788/4885PLA2G4A 4802/4885MAPT 811/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.